FDA Yanks Only Preterm Birth Drug, Effective Immediately

(MedPage Today) -- After a years-long saga, the FDA has withdrawn approval of injectable 17-alpha hydroxyprogesterone caproate (17-OHPC; Makena), which was initially approved over a decade ago to reduce the risk of recurrent preterm birth.
"Effective...

Source: MedPage Today OB/GYN - April 6, 2023 Category: OBGYN Source Type: news